or Try an Advanced Search...

    Technical Analysis for COEP - Coeptis Therapeutics Holdings, Inc

    Grade Last Price % Change Price Change
    F 0.38 1.20% 0.00
    COEP closed up 1.2 percent on Wednesday, May 8, 2024, on 31 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Flat Up
    Historical COEP trend table...
    Date Alert Name Type % Chg
    Crossed Above 50 DMA Bullish 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    50 DMA Resistance Bearish 1.20%
    20 DMA Support Bullish 1.20%
    Doji - Bearish? Reversal 1.20%
    Outside Day Range Expansion 1.20%
    Wide Bands Range Expansion 1.20%
    Gapped Up Strength 1.20%
    Older End-of-Day Signals for COEP ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 17 hours ago
    Possible Inside Day about 18 hours ago
    50 DMA Support about 20 hours ago
    60 Minute Opening Range Breakdown about 22 hours ago
    50 DMA Resistance about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    COEP Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Cell Therapy

    Is COEP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024
    May 2 Coeptis Therapeutics Announces Poster Data Presentation at American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
    Apr 2 Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research Award
    Feb 26 Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK
    Feb 7 Coeptis Therapeutics to Pursue Phase 2 Program Using Proprietary First-in-Class Allogeneic NK Cell Therapy for the Treatment of Viral Infections
    Jan 18 Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying
    Jan 4 Coeptis Therapeutics President and CEO Issues Letter to Shareholders Highlighting 2023 Accomplishments and Outlook for 2024
    Dec 5 Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now
    Dec 4 Coeptis Therapeutics to Present at the Emerging Growth Conference
    See more COEP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.1899
    52 Week Low 0.2851
    Average Volume 251,946
    200-Day Moving Average 0.81
    50-Day Moving Average 0.38
    20-Day Moving Average 0.36
    10-Day Moving Average 0.35
    Average True Range 0.04
    RSI (14) 55.16
    ADX 18.84
    +DI 28.83
    -DI 13.38
    Chandelier Exit (Long, 3 ATRs) 0.36
    Chandelier Exit (Short, 3 ATRs) 0.43
    Upper Bollinger Bands 0.42
    Lower Bollinger Band 0.30
    Percent B (%b) 0.69
    BandWidth 33.06
    MACD Line 0.00
    MACD Signal Line -0.01
    MACD Histogram 0.0067
    Fundamentals Value
    Market Cap 12.94 Million
    Num Shares 34.1 Million
    EPS -0.61
    Price-to-Earnings (P/E) Ratio -0.62
    Price-to-Sales 45.68
    Price-to-Book 3.27
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.42
    Resistance 3 (R3) 0.42 0.40 0.41
    Resistance 2 (R2) 0.40 0.39 0.40 0.41
    Resistance 1 (R1) 0.39 0.39 0.40 0.39 0.41
    Pivot Point 0.38 0.38 0.38 0.38 0.38
    Support 1 (S1) 0.37 0.37 0.37 0.37 0.35
    Support 2 (S2) 0.35 0.36 0.35 0.35
    Support 3 (S3) 0.34 0.35 0.35
    Support 4 (S4) 0.34